Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on November 22, 2017, 10:35:59 am
-
The JNJ-4178 hepatitis C virus (HCV) regimen, jointly developed by Achillion and Janssen, cured high rates of the virus after just six or eight weeks of treatment in a recent trial.
The Phase IIb, multicenter, randomized, open-label OMEGA-1 study included 365 people ages 18 to 70 with genotypes 1, 2, 4 and 5 of hep C who did not have cirrhosis and were either being treated for the first time or had previously been treated with interferon. The trial deliberately excluded anyone with genotype 3 of the virus and anyone previously treated with direct-acting antivirals (DAAs).
Read more...
https://www.hepmag.com/article/high-cure-rates-6-8-weeks-achillions-hep-c-regimen